Clinical Trial Update: Evaluation Of The Success Rate of NOVAMag® SHIELD [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the success rate of NOVAMag SHIELD for alveolar buccal bone dehiscence; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alveolar Bone Dehiscence

Drugs mentioned

• NOVAMag SHIELD

Snippet

Sponsor: Egas Moniz - Cooperativa de Ensino Superior, CRL | Conditions: Alveolar Buccal Bone Dehiscences, Socket Type 3 Subclass B | Phase 4 | Status: RECRUITING